Family Medicine · Honolulu, HI
NPI
1770536443
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
634 Kalihi St, Suite 201
Honolulu, HI, 96819
Phone (808) 841-7288
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
811 services
Medicare patients, 2024
152
Average age 73
Drug cost, 2024
$4.6M
19,740 prescriptions
Company payments, 2025
$7,492
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vicente S Ramo Jr. was code 99214 (office e&m - established), 222 times for 113 patients. In total Vicente S Ramo Jr. billed 811 services in 31 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 222 | 113 | $72.27 | $16K |
| 99213 Office E&M - Established | Office | 177 | 101 | $54.97 | $9,729 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 63 | $12.47 | $1,172 |
| 82947 Clinical Chemistry | Office | 73 | 46 | $3.63 | $265 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 53 | 53 | $126.90 | $6,726 |
| 99497 Care Management/Coordination | Office | 41 | 40 | $51.32 | $2,104 |
| 93000 Electrocardiogram | Office | 28 | 25 | $9.05 | $254 |
| 83036 Blood Count | Office | 23 | 22 | $9.52 | $219 |
| 36415 Venipuncture Blood Collection | Office | 21 | 20 | $8.65 | $182 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 16 | 14 | $57.98 | $928 |
| 80061 Clinical Chemistry | Office | 11 | 11 | $13.12 | $144 |
By year: 2022 $48K for 939 services; 2023 $31K for 490 services; 2024 $40K for 811 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 73 | 46 | $3.63 | $265 |
| 83036 Blood Count | 23 | 22 | $9.52 | $219 |
| 36415 Venipuncture Blood Collection | 21 | 20 | $8.65 | $182 |
| 87428 Infectious Agent Detection by DNA/RNA | 16 | 14 | $57.98 | $928 |
| 80061 Clinical Chemistry | 11 | 11 | $13.12 | $144 |
Medicare prescription drug claims, 2024
In 2024, the drug Vicente S Ramo Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,339 prescriptions and refills. In total Vicente S Ramo Jr. wrote 19,740 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,339 | 3,812 | 445 | $24K |
| Amlodipine Besylate Generic | 1,237 | 3,493 | 406 | $12K |
| Losartan Potassium Generic | 845 | 2,306 | 284 | $9,707 |
| Telmisartan Generic | 810 | 2,350 | 246 | $27K |
| Metformin Hcl Generic | 738 | 2,012 | 256 | $4,977 |
| Rosuvastatin Calcium Generic | 595 | 1,715 | 197 | $15K |
| Farxiga Dapagliflozin Propanediol | 560 | 1,193 | 186 | $676K |
| Metoprolol Succinate Generic | 450 | 1,286 | 154 | $8,088 |
| Allopurinol Generic | 432 | 1,231 | 159 | $4,268 |
| Jardiance Empagliflozin | 395 | 936 | 157 | $551K |
| Levothyroxine Sodium Generic | 394 | 1,108 | 131 | $2,835 |
| Lisinopril Generic | 377 | 995 | 124 | $3,274 |
| Pravastatin Sodium Generic | 334 | 980 | 123 | $5,620 |
| Gabapentin Generic | 330 | 738 | 131 | $5,361 |
| Alendronate Sodium Generic | 311 | 838 | 124 | $4,500 |
Brand drugs: 3,657 claims; generic drugs: 15,891 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vicente S Ramo Jr. $7,492 ($7,492 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,135.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 55 | $2,135 |
| Abbvie Inc. ABBV | 28 | $685 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 20 | $652 |
| Novo Nordisk Inc NVO | 16 | $555 |
| Amgen Inc. AMGN | 20 | $425 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $386 |
| Kowa Pharmaceuticals America, Inc. | 16 | $348 |
| Gilead Sciences, Inc. GILD | 14 | $331 |
| GlaxoSmithKline, LLC. GSK | 18 | $312 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $252 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.